retatrutide clinical trial philippines Phase III study demonstrates 30% weight loss Retatrutide Results: 28.3% Weight Loss

Source: eClinicalMedicine (The Lancet), 2025 53 T1D participants

Among the many updated and iterative products, drugs such as GLP-1 are definitely the most shining ones

With this move, Novo Nordisk strengthens its GLP-1 portfolio in India, where it already markets Rybelsus (oral semaglutide) and Wegovy (obesity management)and enters a competitive space as Eli Lillys Mounjaro is also making inroads

J Biol Chem2743388133887

There is also a preliminary suggestion that semaglutide might help people with tobacco and other drug dependencies ( Annals of Internal Medicine , Aug

some supplier documents use 307.32 g/mol), its monoisotopic exact mass is 307.08380644 Da, and its CAS number is 70-18-8